N = 62 | |
---|---|
Age (yrs, mean ± SD) | 65.97(±11.66) |
Male (n,%) | 35 (56.5) |
Presence of diabetes mellitus (DM) | 24 (38.7) |
Charlson age-comorbidity index (CCI, median, range) | 5 (2–9) |
Preoperative CA19–9 (U/mL, median, range) | 133.1 (2–12,000) |
Postoperative CA19–9 (U/mL, median, range) | 34.4 (0.39–12,000) |
Interval between initial imaging and operation date (mo., median, range) | 0.5 (0.5–20) |
Adjuvant chemotherapy (n,%) | 46 (74.2) |
Location of tumor | |
Head/ Body/Tail | 38/12/12 |
Vascular invasion | 38 (61.3) |
Celiac trunk/SMA/CHA | 7 (11.3) |
PV/SMV/portomesenteric confluence | 16 (25.8) |
Others: IVC, left renal vein | 3 (4.8) |
Conspicuity score > 2 | 25 (40.3) |
Radiologic tumor size (cm) | 2.78(±0.87) |
Resectability | |
Resectable/borderline resectable/unresectable | 37/23/2 |
Presence of obstructive pancreatitis (n, %) | 50 (80.6) |
Presence of double primary cancer (n,%) | 6 (9.6) |